Scott Newsome, DO
Enriched profileProfessor of Clinical Neurology · Johns Hopkins University School of Medicine
Scott Newsome is Professor of Clinical Neurology at Johns Hopkins University School of Medicine. OpenAlex indexes 289 publications with 9,219 citations (h-index 43); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 1 Sept 2026
Scott D. Newsome, DO, is Professor of Clinical Neurology at Johns Hopkins University School of Medicine. The public record shows 289 publications with 9,219 citations (h-index 43), centered on Multiple Sclerosis Research Studies, Autoimmune Neurological Disorders and Treatments, Peripheral Neuropathies and Disorders. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 15 companies.
- Most recent indexed publication: 2026 · Multiple sclerosis (Houndmills, Basingstoke, England)
- Top research focus: Multiple Sclerosis Research Studies
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 98.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- Director
Johns Hopkins Stiff Person Syndrome Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Director
Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 1 Sept 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Trial of eHealth Wellness Behavioral Interventions and Patient-reported Outcomes
Sponsor: Johns Hopkins University
- Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Sponsor: Johns Hopkins University
- Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis
Sponsor: Johns Hopkins University
Industry payments
Updated 1 Sept 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20259 payments$27,127openpaymentsdata.cms.gov ↗
- Genentech USA, Inc.Program year202516 payments$16,769openpaymentsdata.cms.gov ↗
- F. Hoffmann-La Roche AGProgram year20254 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
63.4%Benzodiazepine34.7%Clonazepam50%Diazepam50%Part D≥28 patientsGabapentinoids15.3%Gabapentin73%Pregabalin27%Part D<11 patientsMusculoskeletal
21.6%gamma-Aminobutyric Acid-ergic Agonist11.4%Baclofen100%Part D≥23 patientsCentral alpha-2 Adrenergic Agonist7.2%Tizanidine Hcl100%Part D≥15 patientsCancer & immunology
11%CD20-directed Cytolytic Antibody3.6%Kesimpta Pen100%Part D<11 patientsOther immunosuppressants3.3%Dimethyl Fumarate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 1 Sept 2026
1 congress contribution (2013) across ASCO per OpenAlex. The most recent:
- Progressive multifocal leucoencephalopathy (PML): A novel complication of brentuximab vedotin from the Southern Network on Adverse Reactions (SONAR) project.
ASCO Annual Meeting
ASCO2013Co-authorOnline-only
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 1 Sept 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Influence of OSCAR-IB criteria on test-retest reliability of Spectralis SD-OCT retinal thickness measurements in people with Multiple Sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)
Article2026 - An Unsupervised Approach for Artifact Severity Scoring in Multi-Contrast MR Images.
Proceedings of machine learning research
Article2026 - Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II Study.
Neurology
Clinical Trial2025 - Core diagnostic features of stiff person syndrome: insights from a case-control study.
Journal of neurology
Article2025 - "Will the Real Demyelinating Disorder Please Stand Up?": From the National Multiple Sclerosis Society Case Conference Proceedings.
Neurology(R) neuroimmunology & neuroinflammation
Case Report2025
Most-cited works
by citation count (OpenAlex)Network
Updated 1 Sept 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 1 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/scott-newsome-do
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
realtalkms.com/episode-182-covid-19-vaccine-myth-busting-with-dr-scott-newsome
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →realtalkms.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 1 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Professor of Clinical Neurology
Johns Hopkins University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Attending Neurologist
Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Media & interviews
press, podcasts and appearances- RealTalk MS podcast
Episode 158: "A Deep Dive Into MS Disease-Modifying Therapies with Dr. Scott Newsome"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →realtalkms.com ↗ - RealTalk MS podcast
Episode 182: "COVID-19 Vaccine Myth-Busting with Dr. Scott Newsome"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →realtalkms.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine